Massive U.S. mammography registry aims to sharpen breast cancer detection
NCT ID NCT01900821
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is a large national registry that collects mammography data from radiology practices across the U.S. to help them compare their performance with national and regional benchmarks. It includes up to 8 million participants and provides feedback on key measures like cancer detection and recall rates. The goal is to improve the quality and accuracy of breast cancer screening, not to test a new treatment or drug.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this registry could help improve breast cancer detection rates and reduce unnecessary recalls across the U.S.
- What could go wrong
- This is an observational registry, not a treatment trial. It collects existing data and does not test a new intervention, so direct patient benefits are indirect and long-term.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER SCREENING AND DIAGNOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
ACR
RECRUITINGReston, Virginia, 20190, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.